In the latest issue, find out more about the benefits that
minocycline has shown to have on people living with early-onset
MS, and much more!
In the feature article, you’ll learn about new translational research targeting progressive MS — ground-breaking efforts that will ultimately improve the lives of Canadians living with MS.
In this issue, you’ll also find out about:
- The launch of the historic Canadian Progression Cohort Study, the first of its kind in Canada
- How an MS Society-funded researcher has uncovered the genetic makeup of a type of immune cell implicated in MS
- Not one, but two newly approved drug therapies for relapsing-remitting MS
Research in Action
Research in Action is a bulletin aimed to deliver the latest news on MS research taking place in communities across Canada, and around the world. In addition to breaking news, Research in Action will highlight the latest MS Updates, blog posts from Vice-President, Research Dr. Karen Lee, profiles of researchers and research volunteers, and important upcoming events in MS research.
To subscribe to Research in Action, click here and enter your email address where it says "Stay Updated".